The role of obestatin in glucose and lipid metabolism

Hormone and Metabolic Research

Volumn 45, Issue 13, 2013, Pages 1002-1008

  Gargantini, E ^a   Grande, C ^a   Trovato, L ^a   Ghigo, E ^a   Granata, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

adipogenesis; beta cells; human adipose tissue; insulin secretion; insulin sensitivity; lipid metabolism

Indexed keywords

ABC TRANSPORTER A1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 39; GHRELIN; GHRELIN RECEPTOR; GLUCOKINASE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROGENIN 3; NOTCH RECEPTOR; OBESTATIN; PROTEIN KINASE B; S6 KINASE; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; VISUAL PIGMENT;

ADIPOCYTE; ADIPOSE TISSUE; ANOREXIA NERVOSA; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MUSCLE DEVELOPMENT; NARCOLEPSY; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN SECRETION; REVIEW; WHITE ADIPOSE TISSUE;

RODENTIA;

ADIPOCYTES; ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS; GHRELIN; GLUCOSE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84890548781     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1351325     Document Type: Review

References (90)

1. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature: 1999; 402 656 660 (Pubitemid 129516334)
2. Gutierrez J. A., Solenberg P. J., Perkins D. R., Willency J. A., Knierman M. D., Jin Z., Witcher D. R., Luo S., Onyia J. E., Hale J. E. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA: 2008; 105 6320 6325 (Pubitemid 351758344)
3. Yang J., Brown M. S., Liang G., Grishin N. V., Goldstein J. L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell: 2008; 132 387 396 (Pubitemid 351192001)
4. Seim I., Josh P., Cunningham P., Herington A., Chopin L. Ghrelin axis genes, peptides and receptors: recent findings and future challenges. Mol Cell Endocrinol: 2011; 340 3 9
5. Delhanty P. J., Neggers S. J., van der Lely A. J. Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin. Eur J Endocrinol: 2012; 167 601 608
6. Granata R., Gallo D., Luque R. M., Baragli A., Scarlatti F., Grande C., Gesmundo I., Cordoba-Chacon J., Bergandi L., Settanni F., Togliatto G., Volante M., Garetto S., Annunziata M., Chanclon B., Gargantini E., Rocchietto S., Matera L., Datta G., Morino M., Brizzi M. F., Ong H., Camussi G., Castano J. P., Papotti M., Ghigo E. Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J: 2012; 26 3393 3411
7. Granata R., Baragli A., Settanni F., Scarlatti F., Ghigo E. Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol: 2010; 45 107 118
8. Granata R., Settanni F., Julien M., Nano R., Togliatto G., Trombetta A., Gallo D., Piemonti L., Brizzi M. F., Abribat T., van Der Lely A. J., Ghigo E. Des-acyl ghrelin fragments and analogues promote survival of pancreatic beta-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats. J Med Chem: 2012; 55 2585 2596
9. Sun Y., Wang P., Zheng H., Smith R. G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA: 2004; 101 4679 4684 (Pubitemid 38437470)
10. Muccioli G., Baragli A., Granata R., Papotti M., Ghigo E. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology: 2007; 86 147 164 (Pubitemid 350073603)
11. Lacquaniti A., Donato V., Chirico V., Buemi A., Buemi M. Obestatin: an interesting but controversial gut hormone. Ann Nutr Metab: 2011; 59 193 199
12. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., Bussolino F., Isgaard J., Deghenghi R., Sinigaglia F., Prat M., Muccioli G., Ghigo E., Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol: 2002; 159 1029 1037 (Pubitemid 36055757)
13. Filigheddu N., Gnocchi V. F., Coscia M., Cappelli M., Porporato P. E., Taulli R., Traini S., Baldanzi G., Chianale F., Cutrupi S., Arnoletti E., Ghe C., Fubini A., Surico N., Sinigaglia F., Ponzetto C., Muccioli G., Crepaldi T., Graziani A. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell: 2007; 18 986 994 (Pubitemid 46399502)
14. Granata R., Settanni F., Biancone L., Trovato L., Nano R., Bertuzzi F., Destefanis S., Annunziata M., Martinetti M., Catapano F., Ghe C., Isgaard J., Papotti M., Ghigo E., Muccioli G. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology: 2007; 148 512 529 (Pubitemid 46143157)
15. Zhang J. V., Ren P. G., Avsian-Kretchmer O., Luo C. W., Rauch R., Klein C., Hsueh A. J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science: 2005; 310 996 999 (Pubitemid 41611907)
16. Zizzari P., Longchamps R., Epelbaum J., Bluet-Pajot M. T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology: 2007; 148 1648 1653 (Pubitemid 46457120)
17. Hassouna R., Zizzari P., Viltart O., Yang S. K., Gardette R., Videau C., Badoer E., Epelbaum J., Tolle V. A natural variant of obestatin, Q90L, inhibits ghrelin's action on food intake and GH secretion and targets NPY and GHRH neurons in mice. PLoS ONE: 2012; 7 e51135
18. Bresciani E., Rapetti D., Dona F., Bulgarelli I., Tamiazzo L., Locatelli V., Torsello A. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest: 2006; 29 RC16 RC18 (Pubitemid 44756170)
19. Green B. D., Irwin N., Flatt P. R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides: 2007; 28 981 987 (Pubitemid 46654435)
20. Nagaraj S., Peddha M. S., Manjappara U. V. Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat. Biochem Biophys Res Commun: 2008; 366 731 737
21. Zhang J. V., Jahr H., Luo C. W., Klein C., Van Kolen K., Ver Donck L., De A., Baart E., Li J., Moechars D., Hsueh A. J. Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol Endocrinol: 2008; 22 1464 1475 (Pubitemid 351787005)
22. Kobelt P., Wisser A. S., Stengel A., Goebel M., Bannert N., Gourcerol G., Inhoff T., Noetzel S., Wiedenmann B., Klapp B. F., Tache Y., Monnikes H. Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents. Peptides: 2008; 29 1018 1027
23. Bassil A. K., Haglund Y., Brown J., Rudholm T., Hellstrom P. M., Naslund E., Lee K., Sanger G. J. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol: 2007; 150 58 64 (Pubitemid 46094669)
24. De Smet B., Thijs T., Peeters T. L., Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil: 2007; 19 211 217 (Pubitemid 46239433)
25. Gourcerol G., St-Pierre D. H., Tache Y. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept: 2007; 141 1 7 (Pubitemid 46505037)
26. Chartrel N., Alvear-Perez R., Leprince J., Iturrioz X., Reaux-Le Goazigo A., Audinot V., Chomarat P., Coge F., Nosjean O., Rodriguez M., Galizzi J. P., Boutin J. A., Vaudry H., Llorens-Cortes C. Comment on Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake Science: 2007; 315 766 authors' reply 766
27. Nogueiras R., Pfluger P., Tovar S., Arnold M., Mitchell S., Morris A., Perez-Tilve D., Vazquez M. J., Wiedmer P., Castaneda T. R., DiMarchi R., Tschop M., Schurmann A., Joost H. G., Williams L. M., Langhans W., Dieguez C. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology: 2007; 148 21 26 (Pubitemid 46021434)
28. Pan W., Tu H., Kastin A. J. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides: 2006; 27 911 916
29. Ren G., He Z., Cong P., Chen H., Guo Y., Yu J., Liu Z., Ji Q., Song Z., Chen Y. Peripheral administration of TAT-obestatin can influence the expression of liporegulatory genes but fails to affect food intake in mice. Peptides: 2013; 42C 8 14
30. Granata R., Settanni F., Gallo D., Trovato L., Biancone L., Cantaluppi V., Nano R., Annunziata M., Campiglia P., Arnoletti E., Ghe C., Volante M., Papotti M., Muccioli G., Ghigo E. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes: 2008; 57 967 979
31. Gronberg M., Tsolakis A. V., Magnusson L., Janson E. T., Saras J. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem: 2008; 56 793 801
32. Volante M., Rosas R., Ceppi P., Rapa I., Cassoni P., Wiedenmann B., Settanni F., Granata R., Papotti M. Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol: 2009; 218 458 466
33. Zhao C. M., Furnes M. W., Stenstrom B., Kulseng B., Chen D. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res: 2008; 331 575 587
34. Guo Z. F., Ren A. J., Zheng X., Qin Y. W., Cheng F., Zhang J., Wu H., Yuan W. J., Zou L. Different responses of circulating ghrelin, obestatin levels to fasting, re-feeding and different food compositions, and their local expressions in rats. Peptides: 2008; 29 1247 1254
35. Dun S. L., Brailoiu G. C., Brailoiu E., Yang J., Chang J. K., Dun N. J. Distribution and biological activity of obestatin in the rat. J Endocrinol: 2006; 191 481 489 (Pubitemid 44830624)
36. Karaoglu A., Aydin S., Dagli A. F., Cummings D. E., Ozercan I. H., Canatan H., Ozkan Y. Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol Cell Biochem: 2009; 323 113 118
37. Gurriaran-Rodriguez U., Santos-Zas I., Al-Massadi O., Mosteiro C. S., Beiroa D., Nogueiras R., Crujeiras A. B., Seoane L. M., Senaris J., Garcia-Caballero T., Gallego R., Casanueva F. F., Pazos Y., Camina J. P. The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system. J Biol Chem: 2012; 287 38379 38389
38. Nakahara T., Harada T., Yasuhara D., Shimada N., Amitani H., Sakoguchi T., Kamiji M. M., Asakawa A., Inui A. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry: 2008; 64 252 255 (Pubitemid 351927261)
39. Uehara M., Yasuhara D., Nakahara T., Harada T., Koyama K. I., Ushikai M., Asakawa A., Inui A. Increase in energy intake leads to a decrease in obestatin in restricting-type of anorexia nervosa. Exp Clin Endocrinol Diabetes: 2011; 119 536 539
40. Monteleone P., Serritella C., Martiadis V., Scognamiglio P., Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J Clin Endocrinol Metab: 2008; 93 4418 4421 (Pubitemid 352789541)
41. Germain N., Galusca B., Grouselle D., Frere D., Billard S., Epelbaum J., Estour B. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J Clin Endocrinol Metab: 2010; 95 3057 3062
42. Sedlackova D., Kopeckova J., Papezova H., Vybiral S., Kvasnickova H., Hill M., Nedvidkova J. Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiol Res: 2011; 60 165 173
43. Huda M. S., Mani H., Durham B. H., Dovey T. M., Halford J. C., Aditya B. S., Pinkney J. H., Wilding J. P., Hart I. K. Plasma obestatin and autonomic function are altered in orexin-deficient narcolepsy, but ghrelin is unchanged. Endocrine: 2013; 43 696 704
44. Cui A. D., Gai N. N., Zhang X. H., Jia K. Z., Yang Y. L., Song Z. J. Decreased serum obestatin consequent upon TRIB3 Q84R polymorphism exacerbates carotid atherosclerosis in subjects with metabolic syndrome. Diabetol Metab Syndr: 2012; 4 52
45. Alexandridis E., Zisimopoulos A., Liratzopoulos N., Katsos I., Manolas K., Kouklakis G. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases. Inflamm Bowel Dis: 2009; 15 1557 1561
46. Gao X. Y., Kuang H. Y., Liu X. M., Ma Z. B., Nie H. J., Guo H. Plasma obestatin levels in men with chronic atrophic gastritis. Peptides: 2008; 29 1749 1754
47. Ulasoglu C., Isbilen B., Doganay L., Ozen F., Kiziltas S., Tuncer I. Effect of Helicobacter pylori eradication on serum ghrelin and obestatin levels. World J Gastroenterol: 2013; 19 2388 2394
48. Gronberg M., Tsolakis A. V., Holmback U., Stridsberg M., Grimelius L., Janson E. T. Ghrelin and obestatin in human neuroendocrine tumors: expression and effect on obestatin levels after food intake. Neuroendocrinology: 2013; 97 291 299
49. Lauwers E., Landuyt B., Arckens L., Schoofs L., Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun: 2006; 351 21 25 (Pubitemid 44740415)
50. Holst B., Egerod K. L., Schild E., Vickers S. P., Cheetham S., Gerlach L. O., Storjohann L., Stidsen C. E., Jones R., Beck-Sickinger A. G., Schwartz T. W. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology: 2007; 148 13 20 (Pubitemid 46021433)
51. Zhang J. V., Li L., Huang Q., Ren P. G. Obestatin receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci: 2013; 114 89 107
52. Drucker D. J. The biology of incretin hormones. Cell Metab: 2006; 3 153 165
53. Alloatti G., Arnoletti E., Bassino E., Penna C., Perrelli M. G., Ghe C., Muccioli G. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes. Am J Physiol Heart Circ Physiol: 2010; 299 H470 H481
54. Iglesias M. J., Salgado A., Pineiro R., Rodino B. K., Otero M. F., Grigorian L., Gallego R., Dieguez C., Gualillo O., Gonzalez-Juanatey J. R., Lago F. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism. J Endocrinol Invest: 2007; 30 470 476 (Pubitemid 47496456)
55. Samson W. K., White M. M., Price C., Ferguson A. V. Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol: 2007; 292 R637 R643 (Pubitemid 46089880)
56. Carlini V. P., Schioth H. B., Debarioglio S. R. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun: 2007; 352 907 912 (Pubitemid 44894371)
57. Szentirmai E., Krueger J. M. Obestatin alters sleep in rats. Neurosci Lett: 2006; 404 222 226 (Pubitemid 44063607)
58. Camina J. P., Campos J. F., Caminos J. E., Dieguez C., Casanueva F. F. Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J Cell Physiol: 2007; 211 1 9 (Pubitemid 46363890)
59. Pazos Y., Alvarez C. J., Camina J. P., Casanueva F. F. Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors: 2007; 25 373 381 (Pubitemid 351455003)
60. Granata R., Volante M., Settanni F., Gauna C., Ghe C., Annunziata M., Deidda B., Gesmundo I., Abribat T., van der Lely A. J., Muccioli G., Ghigo E., Papotti M. Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. J Mol Endocrinol: 2010; 45 9 17
61. Favaro E., Granata R., Miceli I., Baragli A., Settanni F., Cavallo Perin P., Ghigo E., Camussi G., Zanone M. M. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways. Diabetologia: 2012; 55 1058 1070
62. Baragli A., Grande C., Gesmundo I., Settanni F., Taliano M., Gallo D., Gargantini E., Ghigo E., Granata R. Obestatin enhances in vitro generation of pancreatic islets through regulation of developmental pathways. PLoS ONE: 2013; 8 e64374
63. Gurriaran-Rodriguez U., Al-Massadi O., Roca-Rivada A., Crujeiras A. B., Gallego R., Pardo M., Seoane L. M., Pazos Y., Casanueva F. F., Camina J. P. Obestatin as a regulator of adipocyte metabolism and adipogenesis. J Cell Mol Med: 2011; 15 1927 1940
64. Miegueu P. St, Pierre D., Broglio F., Cianflone K. Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem: 2011; 112 704 714
65. Pruszynska-Oszmalek E., Szczepankiewicz D., Hertig I., Skrzypski M., Sassek M., Kaczmarek P., Kolodziejski P. A., Mackowiak P., Nowak K. W., Strowski M. Z., Wojciechowicz T. Obestatin inhibits lipogenesis and glucose uptake in isolated primary rat adipocytes. J Biol Regul Homeost Agents: 2013; 27 23 33
66. Aragno M., Mastrocola R., Ghe C., Arnoletti E., Bassino E., Alloatti G., Muccioli G. Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. Cardiovasc Diabetol: 2012; 11 129
67. Granata R., Isgaard J., Alloatti G., Ghigo E. Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone. Exp Biol Med (Maywood): 2011; 236 505 514
68. Kellokoski E., Kunnari A., Jokela M., Makela S., Kesaniemi Y. A., Horkko S. Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. Metabolism: 2009; 58 1572 1580
69. Ceranowicz P., Warzecha Z., Dembinski A., Cieszkowski J., Dembinski M., Sendur R., Kusnierz-Cabala B., Tomaszewska R., Kuwahara A., Kato I. Pretreatment with obestatin inhibits the development of cerulein-induced pancreatitis. J Physiol Pharmacol: 2009; 60 95 101
70. Granata R., Ghigo E. Products of the Ghrelin Gene, the Pancreatic beta-Cell and the Adipocyte. Endocr Dev: 2013; 25 144 156
71. Walia P., Asadi A., Kieffer T. J., Johnson J. D., Chanoine J. P. Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr Res: 2009; 65 39 44
72. Turk N., Dagistanli F. K., Sacan O., Yanardag R., Bolkent S. Obestatin and insulin in pancreas of newborn diabetic rats treated with exogenous ghrelin. Acta Histochem: 2012; 114 349 357
73. Donath M. Y., Halban P. A. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia: 2004; 47 581 589 (Pubitemid 38491259)
74. Hennige A. M., Burks D. J., Ozcan U., Kulkarni R. N., Ye J., Park S., Schubert M., Fisher T. L., Dow M. A., Leshan R., Zakaria M., Mossa-Basha M., White M. F. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest: 2003; 112 1521 1532 (Pubitemid 38056278)
75. Jhala U. S., Canettieri G., Screaton R. A., Kulkarni R. N., Krajewski S., Reed J., Walker J., Lin X., White M., Montminy M. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev: 2003; 17 1575 1580 (Pubitemid 36828785)
76. Cheng H., Straub S. G., Sharp G. W. Inhibitory role of Src family tyrosine kinases on Ca2+-dependent insulin release. Am J Physiol Endocrinol Metab: 2007; 292 E845 E852 (Pubitemid 46411063)
77. Doyle M. E., Egan J. M. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther: 2007; 113 546 593 (Pubitemid 46365961)
78. Terauchi Y., Takamoto I., Kubota N., Matsui J., Suzuki R., Komeda K., Hara A., Toyoda Y., Miwa I., Aizawa S., Tsutsumi S., Tsubamoto Y., Hashimoto S., Eto K., Nakamura A., Noda M., Tobe K., Aburatani H., Nagai R., Kadowaki T. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest: 2007; 117 246 257 (Pubitemid 46048470)
79. Wierup N., Svensson H., Mulder H., Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept: 2002; 107 63 69 (Pubitemid 34876446)
80. Ceranowicz D., Warzecha Z., Dembinski A., Ceranowicz P., Cieszkowski J., Kusnierz-Cabala B., Tomaszewska R., Kuwahara A., Kato I. Role of hormonal axis, growth hormone-IGF-1, in the therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis. J Physiol Pharmacol 61 599 606
81. Qader S. S., Hakanson R., Rehfeld J. F., Lundquist I., Salehi A. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept: 2008; 146 230 237
82. Ren A. J., Guo Z. F., Wang Y. K., Wang L. G., Wang W. Z., Lin L., Zheng X., Yuan W. J. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun: 2008; 369 969 972
83. Egido E. M., Hernandez R., Marco J., Silvestre R. A. Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept: 2009; 152 61 66
84. Ouchi N., Parker J. L., Lugus J. J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol: 2011; 11 85 97
85. Bourron O., Daval M., Hainault I., Hajduch E., Servant J. M., Gautier J. F., Ferre P., Foufelle F. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia: 2010; 53 768 778
86. Grala T. M., Kay J. K., Walker C. G., Sheahan A. J., Littlejohn M. D., Lucy M. C., Roche J. R. Expression analysis of key somatotropic axis and liporegulatory genes in ghrelin- and obestatin-infused dairy cows. Domest Anim Endocrinol: 2010; 39 76 83
87. Yoshizaki T., Milne J. C., Imamura T., Schenk S., Sonoda N., Babendure J. L., Lu J. C., Smith J. J., Jirousek M. R., Olefsky J. M. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol: 2009; 29 1363 1374
88. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest: 2006; 116 1784 1792 (Pubitemid 44033298)
89. Siegrist-Kaiser C. A., Pauli V., Juge-Aubry C. E., Boss O., Pernin A., Chin W. W., Cusin I., Rohner-Jeanrenaud F., Burger A. G., Zapf J., Meier C. A. Direct effects of leptin on brown and white adipose tissue. J Clin Invest: 1997; 100 2858 2864 (Pubitemid 28007556)
90. Kim J. Y., van de Wall E., Laplante M., Azzara A., Trujillo M. E., Hofmann S. M., Schraw T., Durand J. L., Li H., Li G., Jelicks L. A., Mehler M. F., Hui D. Y., Deshaies Y., Shulman G. I., Schwartz G. J., Scherer P. E. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest: 2007; 117 2621 2637 (Pubitemid 47494363)